NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

The good "research" was that FDA halted the trial, and the trial was a failure. A new trial should have been done in 2018, but the problem was that LP knew that even another trial would fail. Her major mistake was taking on GBM first, the hardest cancer to treat because of it's aggressive nature and the blood brain barrier... (which remains an obstacle for all brain diseases)
I am anxious to see how this all plays out. I think it's obvious that an approval with NICE reimbursement is not coming and Advent is not what it once was.